Breaking News

Aizon Closes $20M Series C Funding

This infusion of capital will help Aizon to significantly scale, accelerate its development pipeline, and better serve its customers.

Author Image

By: Charlie Sternberg

Associate Editor

Aizon, an Artificial Intelligence (AI) SaaS provider that transforms pharmaceutical manufacturing operations, has closed $20 million in Series C funding led by NewVale Capital, a growth equity fund that invests in proven, revenue-generating service businesses in pharmaceuticals and biotechnology.   Existing investors Atlantic Bridge, Crosslink Capital, and Uncork Capital also participated in the round.   This infusion of capital, combined with the continued support of key investment partners...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters